Drug
UB Vv400
UB Vv400: highest development phase Phase 1/2, developed by Umoja Biopharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Umoja Biopharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| UB-VV400 NCT07735533 | Phase 1/2 | Lymphoma, B Cell |
Latest
No recent events.
Follow UB Vv400 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.